We are pleased to announce that Ingrid Vande Velde has been elected Chair of the Pharmaceutical Supply Chain Initiative (PSCI).

She succeeds Vicki Stone-Bjarup who completed her chairmanship at the end of 2022 and will transition into her new role as Past Chair. The PSCI Board also welcomed Rajana Ganguly as Treasurer-Designate, Rincy Joseph as Secretary-Designate, and Deirdre O’Reilly as Vice Chair.

Ingrid is a Senior Manager EH&S External Supply EMEA - ASPAC at Johnson & Johnson where she supervises a team of professionals that help ensure EH&S and Sustainability compliance and risk management oversight at external manufacturing and targeted supplier sites. She plays a critical role in protecting supply continuity and safeguarding the J&J reputation by ensuring the J&J Responsibility Standards for Suppliers are deployed, maintained and evaluated. Ingrid has 23 years of experience at Johnson & Johnson in various roles in the EH&S domain, including long-term assignments in the United States of America and China.

Ingrid has been a longstanding and actively engaged member of the PSCI, holding a variety of Committee and leadership roles. She co-led the Capability Committee, helping to successfully grow the PSCI’s Supplier Conference program to reach over 2,000 attendees in China and India. She was also highly involved in the development of the PSCI’s model for supplier learning and development, which provides a structured learning program for suppliers to understand, implement, and evolve their safety, environmental, and social practices in line with the PSCI Principles. In 2022, Ingrid was Vice Chair of the PSCI Board and oversaw the PSCI’s Topic Teams in the development of their curriculum for this new learning model.

In her role as Chair, Ingrid will lead the Board in the delivery of the PSCI’s strategic vision for excellence in safety, environmental, and social outcomes for the whole of the global pharmaceutical and healthcare supply chain.

Speaking about her appointment Ingrid says,

The EH&S and Sustainability opportunities in our supply base are enormous, with new challenges and trends coming our way quickly around environmental and social due diligence as well as chemical regulation. Meanwhile, we cannot lose our focus on key risk areas like industrial hygiene, process safety management, and wastewater treatment. Collaboration and standardization are key to really make a difference in advancing responsible supply chain practices across the pharmaceutical and healthcare industry.

The strength of the PSCI is all about what members bring to the table and even as important, the extended network it organically brings to each of us. I’m delighted to continue my journey as PSCI Chair together with all our members to deliver on our strategy of building responsible supply chains.

The PSCI are also pleased to announce the appointment of Esther Tsang as a member of the PSCI Advisory Panel.

Esther has over 15 years of experience working in global supply chains and has delivered various sustainability and ethical trade programs across multiple sectors.

Esther, originally from Hong Kong and now based in London, has great knowledge of the Asian supply chain and has conducted social audits throughout Asia. She has held multiple positions within the global cosmetics group Natura &Co, focusing on sustainable operations and supply chains, and is now the Scope 3 Net Zero and Sustainable Assurance Manager at The Body Shop.

In her role as a member of the Advisory Panel, Esther will support the PSCI Board to consider long-term strategic questions, scan the horizon for future developments, and challenge their thinking to deliver better outcomes for the PSCI membership and supplier base.

The PSCI Board welcomes Esther and looks forward to working with her to achieve our vision for excellence in safety, environmental, and social outcomes for the whole of the global pharmaceutical and healthcare supply chain.